These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 7471077)

  • 1. Transplantation of primary plasma cell tumor without 2,6,10,14- tetramethylpentadecane (pristane) treatment of the hosts.
    Platica M; Bojko C; Hollander VP
    Cancer Res; 1980 Mar; 40(3):579-81. PubMed ID: 7471077
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of subcutaneously administered 2,6,10,14-tetramethylpentadecane on plasmacytoma growth.
    Platica M; Bojko C; Steiner G; Hollander VP
    Cancer Res; 1980 Jul; 40(7):2229-33. PubMed ID: 6248200
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immune RNA-mediated transfer of tumor antigen responsiveness to unresponsive peritoneal exudate cells from tumor-bearing animals.
    Braun DP; Dray S
    Cancer Res; 1977 Nov; 37(11):4138-44. PubMed ID: 908048
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pristane induces an indomethacin inhibitable inflammatory influx of CD4+ T cells and IFN-gamma production in plasmacytoma-susceptible BALB/cAnPt mice.
    McDonald AH; Degrassi A
    Cell Immunol; 1993 Jan; 146(1):157-70. PubMed ID: 8425224
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Disposition of the plasmacytomagenic alkane pristane (2,6,10,14-tetramethylpentadecane) in mice.
    Janz S; Shacter E
    Cancer Biochem Biophys; 1995 Jun; 15(1):25-34. PubMed ID: 8536217
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lipopolysaccharide and pristane-induced peritoneal exudate requirements for plasma tumor cell colony formation.
    Platica M; Bojko C; Clincea R; Hollander V
    J Natl Cancer Inst; 1982 Feb; 68(2):325-8. PubMed ID: 6950164
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The requirement of an adherent cell substratum for the growth of developing plasmacytoma cells in vivo.
    Cancro M; Potter M
    J Exp Med; 1976 Dec; 144(6):1554-67. PubMed ID: 1003103
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of adherent peritoneal exudate cells on plasmacytoma growth in BALB/c mice.
    Salwa J
    Arch Immunol Ther Exp (Warsz); 1990; 38(3-4):287-90. PubMed ID: 2102661
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of adherent peritoneal exudate cells (APECs) and their products on the RPC-5 plasmacytoma growth in vitro.
    Salwa J
    Arch Immunol Ther Exp (Warsz); 1990; 38(3-4):267-74. PubMed ID: 2102659
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Peritoneal plasmacytomagenesis in mice: comparison of different pristane dose regimens.
    Potter M; Wax JS
    J Natl Cancer Inst; 1983 Aug; 71(2):391-5. PubMed ID: 6576197
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Translocation and activation of protein kinase C by the plasma cell tumor-promoting alkane pristane.
    Janz S; Gawrisch K; Lester DS
    Cancer Res; 1995 Feb; 55(3):518-24. PubMed ID: 7834620
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The bisphosphonate zoledronic acid inhibits the development of plasmacytoma induced in BALB/c mice by intraperitoneal injection of pristane.
    Avcu F; Ural AU; Yilmaz MI; Ozcan A; Ide T; Kurt B; Yalcin A
    Eur J Haematol; 2005 Jun; 74(6):496-500. PubMed ID: 15876253
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cytocidal and cytostatic ability of Corynebacterium liquefaciens in mouse squamous cell carcinoma in vivo.
    Ando K; Urano M; Koike S
    Cancer Res; 1978 Jun; 38(6):1769-73. PubMed ID: 647686
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of plasmacytoma development in BALB/c mice by indomethacin.
    Potter M; Wax JS; Anderson AO; Nordan RP
    J Exp Med; 1985 May; 161(5):996-1012. PubMed ID: 3989472
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Specific pathogen-free BALB/cAn mice are refractory to plasmacytoma induction by pristane.
    Byrd LG; McDonald AH; Gold LG; Potter M
    J Immunol; 1991 Nov; 147(10):3632-7. PubMed ID: 1682379
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Induction of plasma cell tumours with 2,6,10,14-tetramethylpentadecane (pristane) and paraffin oil (paraffinum perliquidum) in BALB/c mice simultaneously exposed to sustained antigenic stimulation with bovine serum albumin (BSA).
    Janz S; Püschel W; Raabe F; Storch H
    Arch Geschwulstforsch; 1987; 57(1):25-30. PubMed ID: 3566462
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Studies on the murine plasma-cell neoplasm, X5563. II. Accelerated immunologic reactivity to transplanted tumor induced in C3H mice by transferred immune rabbit cells.
    Gordon BL II; Fong J
    Ann Allergy; 1967 Sep; 25(9):471-82. PubMed ID: 6053557
    [No Abstract]   [Full Text] [Related]  

  • 18. The immune recognition of TA3 tumors, its facilitation by endotoxin, and abrogation by ascites fluid.
    Grohsman J; Nowotny A
    J Immunol; 1972 Nov; 109(5):1090-5. PubMed ID: 4562425
    [No Abstract]   [Full Text] [Related]  

  • 19. Gas chromatographic-mass spectrometric investigation of four commercial pristane (2.6.10.14-tetramethylpentadecane) preparations used for plasmacytoma induction in BALB/c mice.
    Janz S; Birkenfeld T; Herzschuh R; Storch H
    Arch Geschwulstforsch; 1989; 59(6):415-22. PubMed ID: 2596957
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chromosomal alteration and development of tumors. XIX. Chromosome constitution of tumor cells in 16 plasma cell neoplasms of BALB-c mice.
    Yosida TH; Imai HT; Potter M
    J Natl Cancer Inst; 1968 Nov; 41(5):1083-97. PubMed ID: 4176942
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.